MR1 and prostate carcinoma: Using samples from a cohort of men with prostate cancer and age- and sex-matched controls, we report that circulating MAIT-cells are numerically preserved in prostate cancer but exhibit impaired cytokine production and proliferative capacity in response to the MR-1 ligand 5-A-RU.